E-DRUG: HAI Response - Lancet Commission on Essential Medicines
----------------------------------------------------------------
Dear E-druggers
Health Action International has issued this statement (below) in response to
the report by The Lancet Commission on Essential Medicines Policies, which
will be launched in London today (Tuesday, 8 November, at 14.00 GMT).
The Commissions report is available at
www.thelancet.com/commissions/essential-medicines
To watch a livestream of the launch, go to
https://panopto.lshtm.ac.uk/Panopto/Pages/Viewer.aspx?id=cde64f3f-233b-4f7f-
bcd5-1e8b47d89b68.
Please join us in generating awareness of this very important reportwhich
formalises and legitimises the dire state of global access to medicines and
crucial recommendations to improve itby sharing it widely and calling on
policymakers to implement the recommendations.
Best regards,
Bobbi Klettke
Communications, Health Action International
HEALTH ACTION INTERNATIONAL RESPONSE TO REPORT BY LANCET COMMISSION ON
ESSENTIAL MEDICINES
Reports by Lancet Commission and High-level Panel on Access to Medicines
expose dire state of global access to medicines and provide blueprint to fix
flawed system for medicines access and innovation
AMSTERDAM
As a member of The Lancet Commission on Essential Medicines and a non-profit
consumer organisation dedicated to improving global access to medicines,
Health Action International welcomes the Lancet Commissions report,
Essential Medicines for Universal Health Coverage.
The Commissions recommendations are not new, but new recommendations are
not needed. It is the momentum generated by the report that must not be
allowed to falter.
Together, the reports by The Lancet Commission and the United Nations High
Level Panel on Access to Medicines provide a damning indictment of the
global access to medicines situation. More importantly, they provide a
blueprint for change.
To improve access to essential medicines, it is imperative that all
governments fully implement the recommendations laid out in these reports.
This is a necessity if governments truly wish to achieve universal health
coverage and uphold their citizens right to health.
In addition, the World Health Organization (WHO) must provide strong and
consistent leadership and support to governments implementing these
recommendations. We appeal to the new Director-General, who will take office
next July, to unreservedly champion access to medicines policy reform among
member states.
Health Action International will continue to work with our members and
partners to hold global health and government leaders to account. We will
press governments to enact and enforce the policy recommendations laid out
by the Commission and High-level Panel, and the WHO to deliver on its role
as a leader for universal access to medicines.
For comment and additional information, please contact:
Bobbi Klettke, Communications, Health Action International
E: bobbi@haiweb.org | T: +31 20 412 4523 | M: +31 68 142 3206 |
www.haiweb.org
-END-